A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
China Lymphoma Patient Registry Study
- Status
- RECRUITING
- Phase
- N/A
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Image-guided Lymphadanectomy in AMIGO
- Status
- TERMINATED
- Phase
- NA
Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL
- Status
- UNKNOWN
- Phase
- PHASE1
Sample Collection and Tracking for the Developmental Therapeutics Clinic
- Status
- RECRUITING
- Phase
- N/A
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship
- Status
- COMPLETED
- Phase
- NA
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)
- Status
- TERMINATED
- Phase
- PHASE1
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
- Status
- COMPLETED
- Phase
- NA
Pedometer Activity Monitoring After ASCT
- Status
- COMPLETED
- Phase
- PHASE2
A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
The CAROLE (CArdiac Related Oncologic Late Effects) Study
- Status
- COMPLETED
- Phase
- N/A
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1